Posted Dec. 18, 2013 at 1:50 p.m.

Premium Lock COPD drug from GSK, Theravance gets FDA approval

Published: 2013-12-18 13:50:49
Updated: 2013-12-18 13:50:49

Print this blog post
Lung disease Lung disease Image 1 of 2 · Next Image…

GlaxoSmithKline and Theravance received FDA approval on Anoro Ellipta, a drug indicated for treating chronic obstructive pulmonary disease (COPD). Read more about the drug and GSK's launch plans....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll